Cargando…
Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.
Murine monoclonal antibodies directed against tumour associated antigens are potentially useful in tumour diagnosis and therapy. However, all the antigens they recognise may be heterogeneously expressed on tumours and this may allow escape of cells from therapy if a single monoclonal antibody is use...
Autores principales: | Durrant, L. G., Robins, R. A., Ballantyne, K. C., Marksman, R. A., Hardcastle, J. D., Baldwin, R. W. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2247249/ https://www.ncbi.nlm.nih.gov/pubmed/2481485 |
Ejemplares similares
-
Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.
por: Durrant, L. G., et al.
Publicado: (1987) -
Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.
por: Durrant, L. G., et al.
Publicado: (1987) -
Immunolocalization of the murine monoclonal antibody, 791T/36 within primary human colorectal carcinomas and identification of the target antigen.
por: Price, M. R., et al.
Publicado: (1984) -
A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.
por: Pimm, M. V., et al.
Publicado: (1990) -
Antigenicity of newly established colorectal carcinoma cell lines.
por: Durrant, L. G., et al.
Publicado: (1986)